Caffeine and headaches

Neurological Sciences

Volumn 28, Issue SUPPL. 2, 2007, Pages

  Shapiro, Robert E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Adenosine; Caffeine; Headache; Migraine

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; ANALGESIC AGENT; CAFFEINE; PARACETAMOL;

ADJUVANT THERAPY; ANALGESIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CHRONIC DAILY HEADACHE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIETARY INTAKE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG POTENTIATION; DRUG USE; HEADACHE; HUMAN; LOW DRUG DOSE; META ANALYSIS; MIGRAINE; MONOTHERAPY; POSTDURAL PUNCTURE HEADACHE; PREVALENCE; REPEATED DRUG DOSE; RISK FACTOR; SYSTEMATIC REVIEW; TENSION HEADACHE; WITHDRAWAL SYNDROME;

ADENOSINE; BRAIN; CAFFEINE; DRUG COMBINATIONS; DRUG SYNERGISM; HEADACHE DISORDERS; HEADACHE DISORDERS, SECONDARY; HUMANS; RECEPTORS, PURINERGIC P1; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34249294492     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0773-5     Document Type: Article

References (56)

1. Frary CD, Johnson RK, Wang MQ (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105:110-113
2. Barone JJ, Roberts HR (1996) Caffeine consumption. Food Chem Toxicol 34:119-129
3. Fredholm BB, Battig K, Holmen J et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharm Rev 51:83-133
4. Spiller GA (1998) Caffeine. CRC Press, Boca Raton, Fla.
5. Migliardi JR, Armellino JJ, Friedman M et al (1994) Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 56:576-586
6. Lipton RB, Stewart WF, Ryan RE et al (1998) Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain. Arch Neurol 55:210-217
7. Diener HC, Pfaffenrath V, Pageler L et al (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: A multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25:776-787
8. Thithapandha A (1989) Effect of caffeine on the bioavailability and pharmacokinetics of aspirin. J Med Assoc Thai 72:562-566
9. Iqbal N, Ahmad B, Janbaz KH et al (1995) The effect of caffeine on the pharmacokinetics of acetaminophen in man. Biopharm Drug Dispos 16:481-487
10. Zhang WY (2001) A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf 24:1127-1142
11. Ward N, Whitney C, Avery D, Dunner D (1991) The analgesic effects of caffeine in headache. Pain 44:151-155
12. Diamond S, Balm TK, Freitag FG (2000) Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 68:312-319
13. Camann WR, Murray RS, Mushlin PS, Lambert DH (1990) Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial. Anesth Analg 70:181-184
14. Yucel A, Ozyalcin S, Talu GK et al (1999) Intravenous administration of caffeine sodium benzoate for postdural puncture headache. Reg Anesth Pain Med 24:51-54
15. Esmaoglu A, Akpinar H, Uqur F (2005) Oral multidose caffeine-paracetamol combination is not effective for the prophylaxis of postdural puncture headache. J Clin Anesth 17:58-61
16. Dreisbach RH, Pfeiffer C (1943) Caffeine-withdrawal headache. J Lab Clin Med 28:1212-1219
17. Silverman K, Evans SM, Strain EC, Griffiths RR (1992) Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 327:1109-1114
18. Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 176:1-29
19. Juliano LM (2004) The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 24[Suppl 1]:1-160
20. Evans SM, Griffiths RR (1999) Caffeine withdrawal: A parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 289:285-294
21. Kendler KS, Prescott CA (1999) Caffeine intake, tolerance, and withdrawal in women: A population-based twin study. Am J Psychiatry 156:223-228
22. Courturier EGM, Hering R, Steiner TJ (1992) Weekend attacks in migraine patients: Caused by caffeine withdrawal? Cephalalgia 12:99-100
23. Mosek A, Korczyn AD (1995) Yom Kippur headache. Neurology 45:1953-1955
24. Sjaastad O, Bakketeig LS (2004) Caffeine-withdrawal headache. The Vågå study of headache epidemiology. Cephalalgia 24:241-249
25. Usmani OS, Belvisi MG, Patel HJ et al (2005) Theobromine inhibits sensory nerve activation and cough. FASEB J 19:231-233
26. Kallenborn R, Weigel S, Jensen E, Hühnerfuss H (2003) Pharmaceutical residues in the northern Norwegian environment. Geological Society of America Abstracts with Programs 35:143
27. Griffiths RR, Chausmer AL (2000) Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement. Jpn J Neuropsychopharmacol 20:223-231
28. Hughes JR, Oliveti AH, Liguori A et al (1998) Endorsement of DSM-IV dependence criteria among caffeine users Drug Alcohol Depend 52:99-107
29. Daly JW, Fredholm BB (1998) Caffeine - an atypical drug of dependence. Drug Alcohol Depend 51:199-206
30. Schuh KJ, Griffiths RR (1997) Caffeine reinforcement: The role of withdrawal. Psychopharmacology (Berl) 130:320-326
31. Rogers PJ, Martin J, Smith C et al (2003) Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology (Berl) 167:54-62
32. Bigal M, Sheftell FD, Rapoport AM et al (2002) Chronic daily headache: identification of factors associated with induction and transformation. Headache 42:575-581
33. Takeshima T, Ishizaki K, Fukuhara Y et al (2004) Populationbased door-to-door survey of migraine in Japan: The Daisen study. Headache 44:1-12
34. Scher AI, Stewart WF, Lipton RB (2004) Caffeine as a risk factor for chronic daily headache. Neurology 63:2022-2027
35. Feinstein AR, Heinemann LAJ, Dalessio D et al (2000) Do caffeine-containing analgesics promote dependence? A review and evaluation. Clin Pharmacol Ther 68:457-467
36. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55
37. Fox AW, Davis RL (1998) Migraine chronobiology. Headache 38:436-441
38. Mathew RJ, Wilson WH (1985) Caffeine induced changes in cerebral circulation. Stroke 16:814-817
39. Conlay LA, Conant JA, deBros F,Wurtman R (1997) Caffeine alters plasma adenosine levels. Nature 389:136-137
40. Couturier EGM, Laman DM, van Duijn MAJ, van Duijn H (1997) Influence of caffeine and caffeine withdrawal on headache and cerebral blood velocities. Cephalalgia 17:188-190
41. Jones HE, Herning RI, Cadet JL, Griffiths RR (2000) Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology (Berl) 147:371-377
42. Field AS, Laurienti PJ,Yen Y-F et al (2003) Dietary caffeine consumption and withdrawal: Confounding variables in quantitative cerebral perfusion studies. Radiology 227:129-135
43. Hardebo JE, Edvinsson L (1979) Adenine compounds: Cerebrovascular effects in vitro with reference to their possible involvement in migraine. Stroke 10:58-62
44. Burnstock G (1981) Pathophysiology of migraine: A new hypothesis. Lancet 1:1397-1399
45. Burnstock G (1989) The role of adenosine triphosphate in migraine. Biomed Pharmacother 43:727-736
46. Wolff HG (ed) (1948) Headache and other pain. Oxford University Press, Oxford
47. Guieu R, Devaux C, Henry H et al (1998) Adenosine and migraine. Can J Neurol Sci 25:55-58
48. Brown SG, Waterer GW (1995) Migraine precipitated by adenosine. Med J Aust 162:389-391
49. Hawkes CH (1978) Dipyridamole in migraine. Lancet 2:153
50. Fredholm BB (1982) Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand 115:283-286
51. Johansson B, Georgiev V, Lindstrom K, Fredholm BB (1997) A1 and A2A adenosine receptors and A1 mRNA in mouse brain: Effect of long-term caffeine treatment. Brain Res 762:153-164
52. Varani K, Portaluppi F, Merighi S et al (1999) Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499-2502
53. Jacobson KA, von Lubitz DKJE, Daly JW, Fredholm BB (1996) Adenosine receptor ligands: Differences with acute versus chronic treatment. Trends Pharmacol Sci 17:108-113
54. Taiwo YO, Levine JD (1991) Further confirmation of the role of adenylyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44:131-135
55. Santicioli P, Del Bianco E, Maggi CA (1993) Adenosine A1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur J Pharmacol 231:139-142
56. Carruthers AM, Sellers LA, Jenkins DW et al (2001) Adenosine A1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol Pharmacol 59:1533-1541